Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

Similar articles for PubMed (Select 22326922)

1.

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.

van den Eertwegh AJ, Versluis J, van den Berg HP, Santegoets SJ, van Moorselaar RJ, van der Sluis TM, Gall HE, Harding TC, Jooss K, Lowy I, Pinedo HM, Scheper RJ, Stam AG, von Blomberg BM, de Gruijl TD, Hege K, Sacks N, Gerritsen WR.

Lancet Oncol. 2012 May;13(5):509-17. doi: 10.1016/S1470-2045(12)70007-4. Epub 2012 Feb 10.

PMID:
22326922
2.

Error occurred: cannot get document summary

PMID:
26130065

3.

Safety of Infusing Ipilimumab Over 30 Minutes.

Momtaz P, Park V, Panageas KS, Postow MA, Callahan M, Wolchok JD, Chapman PB.

J Clin Oncol. 2015 Jun 29. pii: JCO.2015.61.0030. [Epub ahead of print]

PMID:
26124475
4.

Radiographic Profiling of Immune-related Adverse Events in Advanced Melanoma Patients Treated With Ipilimumab.

Tirumani SH, Ramaiya NH, Keraliya A, Bailey N, Ott PA, Hodi FS, Nishino M.

Cancer Immunol Res. 2015 Jun 22. pii: canimm.0102.2015. [Epub ahead of print]

PMID:
26100356
5.

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

Golden EB, Chhabra A, Chachoua A, Adams S, Donach M, Fenton-Kerimian M, Friedman K, Ponzo F, Babb JS, Goldberg J, Demaria S, Formenti SC.

Lancet Oncol. 2015 Jun 18. pii: S1470-2045(15)00054-6. doi: 10.1016/S1470-2045(15)00054-6. [Epub ahead of print]

PMID:
26095785
6.

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.

Kübler H, Scheel B, Gnad-Vogt U, Miller K, Schultze-Seemann W, Vom Dorp F, Parmiani G, Hampel C, Wedel S, Trojan L, Jocham D, Maurer T, Rippin G, Fotin-Mleczek M, von der Mülbe F, Probst J, Hoerr I, Kallen KJ, Lander T, Stenzl A.

J Immunother Cancer. 2015 Jun 16;3:26. doi: 10.1186/s40425-015-0068-y. eCollection 2015.

7.

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

Podrazil M, Horvath R, Becht E, Rozkova D, Bilkova P, Sochorova K, Hromadkova H, Kayserova J, Vavrova K, Lastovicka J, Vrabcova P, Kubackova K, Gasova Z, Jarolim L, Babjuk M, Spisek R, Bartunkova J, Fucikova J.

Oncotarget. 2015 May 29. [Epub ahead of print]

8.

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients.

Cusi MG, Botta C, Pastina P, Rossetti MG, Dreassi E, Guidelli GM, Fioravanti A, Martino EC, Gandolfo C, Pagliuchi M, Basile A, Carbone SF, Ricci V, Micheli L, Tassone P, Tagliaferri P, Pirtoli L, Correale P.

Cancer Immunol Immunother. 2015 Jun 2. [Epub ahead of print]

PMID:
26031574
9.

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination.

Paller CJ, Rudek MA, Zhou XC, Wagner WD, Hudson TS, Anders N, Hammers HJ, Dowling D, King S, Antonarakis ES, Drake CG, Eisenberger MA, Denmeade SR, Rosner GL, Carducci MA.

Prostate. 2015 May 27. doi: 10.1002/pros.23024. [Epub ahead of print]

PMID:
26012728
10.

Ipilimumab-induced hypophysitis in melanoma patients: An Australian case series.

Lam T, Chan MM, Sweeting AN, De Sousa SM, Clements A, Carlino MS, Long GV, Tonks K, Chua E, Kefford RF, Chipps DR.

Intern Med J. 2015 May 26. doi: 10.1111/imj.12819. [Epub ahead of print]

PMID:
26010858
11.

Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial.

Maeda Y, Yoshimura K, Matsui H, Shindo Y, Tamesa T, Tokumitsu Y, Hashimoto N, Tokuhisa Y, Sakamoto K, Sakai K, Suehiro Y, Hinoda Y, Tamada K, Yoshino S, Hazama S, Oka M.

Cancer Immunol Immunother. 2015 May 16. [Epub ahead of print]

PMID:
25982372
12.

Pre-existing levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab.

Kwek SS, Lewis J, Zhang L, Weinberg V, Greaney S, Harzstark A, Lin A, Ryan C, Small EJ, Fong L.

Cancer Immunol Res. 2015 May 12. pii: canimm.0227.2014. [Epub ahead of print]

PMID:
25968455
14.

[Metastasized prostate cancer : Position paper on the use of chemotherapy].

Ohlmann CH, Duensing S, Eichenauer R, König F, Machtens S, Schostak M, Thomas C, Albers P.

Urologe A. 2015 May 10. [Epub ahead of print] German.

PMID:
25962469
15.

Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab.

Uslu U, Agaimy A, Hundorfean G, Harrer T, Schuler G, Heinzerling L.

J Immunother. 2015 Jun;38(5):212-5. doi: 10.1097/CJI.0000000000000081.

PMID:
25962110
16.

Ipilimumab-induced hypophysitis: review of the literature.

Araujo PB, Coelho MC, Arruda M, Gadelha MR, Neto LV.

J Endocrinol Invest. 2015 May 10. [Epub ahead of print]

PMID:
25957829
18.

Ipilimumab-induced colitis in patients with metastatic melanoma.

De Felice KM, Gupta A, Rakshit S, Khanna S, Kottschade LA, Finnes HD, Papadakis KA, Loftus EV Jr, Raffals LE, Markovic SN.

Melanoma Res. 2015 Apr 29. [Epub ahead of print]

PMID:
25933207
19.

A randomized phase II trial of sipuleucel-T with concurrent vs sequential abiraterone acetate plus prednisone in metastatic castration resistant prostate cancer.

Small EJ, Raymond L, Gardner TA, Karsh LI, Fong L, McCoy C, DeVries T, Sheikh NA, GuhaThakurta D, Chang N, Redfern CH, Shore ND.

Clin Cancer Res. 2015 Apr 29. pii: clincanres.0079.2015. [Epub ahead of print]

PMID:
25925891
20.

Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.

Horinouchi H, Yamamoto N, Fujiwara Y, Sekine I, Nokihara H, Kubota K, Kanda S, Yagishita S, Wakui H, Kitazono S, Mizugaki H, Tokudome T, Tamura T.

Invest New Drugs. 2015 May 1. [Epub ahead of print]

PMID:
25924991
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk